Abstract
Pharmacovigilance also known as Drug Safety, is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. The etymological roots for the word "Pharmacovigilance" are: pharmakon (Greek for drug) and vigilare (Latin for to keep watch). As such, Pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy. (The condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological function was excluded with the latest amendment of the applicable legislation.) Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest (even without adverse event itself), because they may result in an ADR. Pharmacists with their immense knowledge of medication use can play role in the detection, prevention, and management of ADRs. The present revised study shows poor knowledge and lack of awareness among healthcare professionals. So there is urgent need to develop awareness about Pharmacovigilance and ADRs reporting among Health Care Professionals.
